Becton, Dickinson and Company (BVMF:B1DX34)
Brazil
· Delayed Price · Currency is BRL 203.57
+0.93 (0.46%)
At close: Dec 4, 2025
BVMF:B1DX34 Revenue
In the fiscal year ending September 30, 2025, Becton, Dickinson and Company had annual revenue of $21.84B USD with 8.24% growth. Becton, Dickinson and Company had revenue of $5.89B in the quarter ending September 30, 2025, with 8.35% growth.
Revenue
$21.84B
Revenue Growth
+8.24%
P/S Ratio
2.57
Revenue / Employee
$303.33K
Employees
72,000
Market Cap
299.64B BRL
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 21.84B | 1.66B | 8.24% |
| Sep 30, 2024 | 20.18B | 806.00M | 4.16% |
| Sep 30, 2023 | 19.37B | 502.00M | 2.66% |
| Sep 30, 2022 | 18.87B | -261.00M | -1.36% |
| Sep 30, 2021 | 19.13B | 3.06B | 19.02% |
| Sep 30, 2020 | Pro | Pro | Pro |
| Sep 30, 2019 | Pro | Pro | Pro |
| Sep 30, 2018 | Pro | Pro | Pro |
| Sep 30, 2017 | Pro | Pro | Pro |
| Sep 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rede D'Or São Luiz | 54.20B |
| Raia Drogasil | 42.23B |
| Hypera | 6.97B |
| Fleury | 8.07B |
| Odontoprev | 2.53B |
| Diagnósticos da América | 12.57B |
| Empreendimentos Pague Menos | 14.27B |
| Blau Farmacêutica | 1.77B |